OraSure Technologies, Inc. (OSUR) vs X4 Pharmaceuticals, Inc. (XFOR)
A side-by-side comparison of OraSure Technologies, Inc. and X4 Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
OSUR
OraSure Technologies, Inc.
$3.81HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
XFOR
X4 Pharmaceuticals, Inc.
$2.76HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
Total return — OSUR vs XFOR
growth of $100 · dividends reinvested · last 9yOSUR -71.4% (-13.0%/yr)XFOR -99.9% (-52.9%/yr)OSUR compounded faster over this window
Log scale — wide-divergence pair
OSUR XFOR
OSUR vs XFOR: by the numbers
- •OSUR is the larger company ($262M vs $261M market cap).
- •Both run net losses; OSUR's is the smaller (-43.70% vs -568.80% net margin).
Metrics side by side
Valuation
| Metric | OSUR | XFOR |
|---|---|---|
| P/S ratio | 2.33 | 16.44 |
| P/B ratio | 0.82 | 1.68 |
Profitability
| Metric | OSUR | XFOR |
|---|---|---|
| Gross margin | 41.38% | 81.22% |
| Operating margin | -59.23% | -247.44% |
| Net margin | -43.70% | -568.80% |
| ROE | -15.46% | -57.98% |
| ROIC | -15.00% | -37.61% |
Growth (annualized)
| Metric | OSUR | XFOR |
|---|---|---|
| Revenue CAGR (5Y) | -13.12% | N/A |
| Total return CAGR (5Y) | -17.56% | -55.06% |
Frequently asked
- How have OSUR and XFOR total returns compared?
- Over the past 5 years, OSUR delivered -17.56% and XFOR delivered -55.06% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.